Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yohei Doi's publication output changed over time?
ScholarIQpublication output · 2007–2020
Output grew100% over the shown period — from 1 works in 2007 to 2 in 2020.
1
1
2
1
4
1
2
2007201220152016201720192020
What are the most-cited papers on Yohei Doi?
ScholarIQmost cited works
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yiyun Liu, Yang Wang, Timothy R. Walsh, Lingxian Yi, Rong Zhang, James Spencer, Yohei Doi, Guo‐Bao Tian, Baolei Dong, Xi Huang, Lin-feng Yu, Danxia Gu, Hongwei Ren, Xiaojie Chen, Luchao Lv, Dandan He, Hongwei Zhou, Liang ZiSen, Jian–Hua Liu, Jianzhong Shen
S23772524. 20155,419 Citations
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin, Yohei Doi
S2484688887. 2016998 CitationsOPEN ACCESS
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti, Roger Echols, Yuko Matsunaga, Mari Ariyasu, Yohei Doi, Ricard Ferrer, Thomas P. Lodise, Thierry Naas, Yoshihito Niki, David L. Paterson, Simon Portsmouth, Julián Torre‐Cisneros, Kiichiro Toyoizumi, Richard G. Wunderink, Tsutae Den Nagata
S23772524. 2020810 Citations
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
Mohamed Abd El-Gawad El-Sayed Ahmed, Lan-Lan Zhong, Cong Shen, Yongqiang Yang, Yohei Doi, Guo‐Bao Tian
S2764760790. 2020757 CitationsOPEN ACCESS
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Yohei Doi
S72350973. 2019679 CitationsOPEN ACCESS
Related on ScholarIQ
Fujita Health University
Institution
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Paper
The global epidemiology of carbapenemase-producing Enterobacteriaceae
Paper
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Paper
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
Paper
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Paper